Interim Management Statement

RNS Number : 6996L

Victrex PLC

04 August 2011

 



4 August 2011

Victrex plc

Interim Management Statement

This statement comprises Victrex's Interim Management Statement covering the period from 1 April 2011 to date.

Group sales volume in the third quarter was 750 tonnes, an increase of 8% over the third quarter of the previous financial year (695 tonnes). This brings the year to date volumes to 2,184 tonnes, an increase of 17% over the same period of the previous financial year (1,866 tonnes).

Invibio^®, our biomaterial solutions business, has continued to trade in line with expectations.

The Company continues to perform in line with expectations. It remains in an excellent financial position with a healthy balance sheet, strong cash generation, and no significant changes in its financial position since 31 March 2011. Consequently we believe we are well placed to pursue future growth and investment opportunities across the business.

The Company's annual trading update for the year ending 30 September 2011 will be issued on Thursday 6 October 2011.

Enquiries

Victrex plc

Peter Bream, Finance Director                            0203 128 8100 (4 August 2011)

                                                                              01253 897 700 (thereafter)

MHP Communications

Nick Denton / Barnaby Fry / Ian Payne                 0203 128 8100

Victrex plc is an innovative world leader in high performance materials through the manufacture of VICTREX^® PEEK™ polymer, a high performance, easy to process thermoplastic.

With over 30 years of experience, Victrex is a global manufacturer of innovative, high performance thermoplastic polymers. We work with customers and end users to deliver technology driven solutions to the challenges and opportunities they face. Our Victrex Polymer Solutions business ('VPS') focuses on our transport, industrial and electronics markets and our Invibio Biomaterial Solutions business ('Invibio') focuses on providing specialist solutions for medical device manufacturers.

 

END

 

 

IMSEASPDELSFEFF